Paul M Silva Insider Trades & Stock Holdings

Director · Rapport Therapeutics, Inc. · Latest filing Oct 22, 2026

Paul M Silva, Director at Rapport Therapeutics, Inc. has 1 Form 4 trade on file since Oct 22, 2026. Open-market activity: 1 purchase ($99.64K) and 0 sales ($0), net +$99.64K. Latest filing: acquired 3.68K shares of $RAPP on Oct 22, 2026 at $27.07.

Trades on file

1

Open-market bought

$99.64K

Open-market sold

$0

Net open-market

+$99.64K

Shares held ($RAPP)

3.68K

Latest filing

Oct 22, 2026

Shares held by Paul M Silva

• $RAPP3.68K sh

Shares owned after the most recent Form 4 for each company.

All insider trades by Paul M Silva

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Oct 22, 2026	$RAPP	Buy (Open-market buy)	3.68K	$27.07	$99.64K	3.68K					Director	SEC	Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Paul M Silva traded

• $RAPP

Frequently asked questions

Has Paul M Silva been buying or selling stock?

Paul M Silva has 1 open-market purchase and 0 open-market sales on file, net +$99.64K. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Paul M Silva's latest insider trade?

acquired 3.68K shares of $RAPP on Oct 22, 2026 at $27.07.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.